ProductLife Group is pleased to announce its participation in the World Drug Safety Congress Europe 2025, which will take place in Amsterdam on 7–8 October 2025. Recognised as a premier global forum, the event brings together leading pharmaceutical, biotech, and medtech companies, as well as regulators and patient safety experts, to shape the future of pharmacovigilance and drug safety.
Attendees will find ProductLife Group at booth 21a, where our team will be available to discuss how PLG supports clients in advancing global patient safety through comprehensive vigilance solutions and innovative approaches.
On 7 October at 12:20 (Compliance Track), Lucy Green, Director of Local Safety PV Line of Business, will join a panel discussion to share her expertise on compliance and best practices in patient safety.
The World Drug Safety Congress has become one of the most important international forums for the pharmacovigilance and safety community. Each year it brings together senior leaders, including Heads of Global Safety, QPPVs, and Chief Safety Officers, to exchange perspectives on the future of patient safety. The congress also serves as a stage to showcase the latest innovations in safety systems, digital technologies, and artificial intelligence, while offering practical insights into how organisations can strengthen compliance and, ultimately, safeguard patients worldwideEnd-to-end vigilance solutions from PLG
The themes of the World Drug Safety Congress closely reflect the breadth of expertise that ProductLife Group brings to the field of pharmacovigilance. Our teams work across the entire safety lifecycle, supporting organisations in areas such as:
Our experts look forward to welcoming you and exchanging perspectives on the future of patient safety:
Hélène Masset, Lucy Green, Maria Skou Andersen, Lewis Atkinson, Natasha Ibrahim, Oumaima Drira, Andrea Pieri, Laura Mayombo, Sarah Sendrup, Bianca Shrans, and Eva Kollée.
Go to our Events to register
Go to our News to get insights